📅Offer Date: 30 Jul 2024 – 01 Aug 2024
Data sourced from BSE & NSE · Last updated
Akums Drugs and Pharmaceuticals Limited IPO was subscribed 63.44x in total when bidding closed on 01 Aug 2024, with 90.09x in the QIB category, 42.10x in NII, 20.80x in retail. The issue ran from 30 Jul 2024 to 01 Aug 2024 at a price band of ₹646.00–₹679.00 per share.
Times subscribed by category against the 1× line.
Based on retail subscription (20.80x). Final allotment decided by registrar's computerised lottery.
| Category | Offer | Applied | Times |
|---|---|---|---|
| QIBs | 81,37,276 | 73,30,87,195 | 90.09x |
| NIIs | 40,68,637 | 17,12,89,618 | 42.10x |
| SNIIs (<10L) | 13,56,212 | 4,26,52,867 | 31.45x |
| BNIIs (>10L) | 27,12,425 | 12,86,50,318 | 47.43x |
| Retail | 27,12,424 | 5,64,18,419 | 20.80x |
| Total | 1,51,62,239 | 96,18,92,442 | 63.44x |
| Category | Offered | Demand | Times |
|---|---|---|---|
| QIBs | 552.52 | 49776.62 | 90.09x |
| NIIs | 276.26 | 11630.57 | 42.10x |
| Retail | 184.17 | 3830.81 | 20.80x |
| Total | 1012.96 | 65238.00 | 63.44x |
Values derived from share count × issue price (₹679.00)
Because Akums Drugs and Pharmaceuticals Limited closed oversubscribed, allotment follows the applicable category and exchange rules. A high subscription figure reflects strong demand but does not guarantee a premium listing, and a low figure does not guarantee a discount. This page is for information only and is not investment advice.
BSE, NSE listed · Bidding data sourced from BSE & NSE under SEBI ICDR regulations.